Food allergies and gluten-related disorders are on the rise,
with significant social, health, and economic impact
$25B
each year is spent on healthcare costs related to food allergies and disorders
1 in every 13 children in
the United States is affected by food allergies
new cases of celiac
disease have doubled every fifteen years
Ukko’s computational engineering platform
re-designs food allergens, turning them into safe and efficacious therapeutics that will become best in class therapy for allergy
We are building a comprehensive, clinically validated map of the molecular structure of food allergies, unlocking critical knowledge about the biological mechanisms that drive human-food interactions.
On the basis of this map, we use platform to design new versions of the proteins that do not trigger an immune response. These proteins allow a whole new approach for how we treat protein based allergies.
Founding Team
ANAT BINUR
CEO & Co-Founder
YANAY OFRAN
Chairman & Co-Founder
Our Advisors
DR. TIM GARNETT
Former CMO and SVP, Eli-Lily
PROF. LYNDA SCHNEIDER
Director, Allergy Program
Boston Children’s Hospital
Professor of Pediatrics, Harvard Medical School
DR. WESLEY A. BURKS
Stuart Bondurant Distinguished Professor
Dean and CEO UNC School of Medicine and UNC Health
PROF. STEPHEN DRESKIN
Medical Director, Allergy and Clinical Immunology
Professor of Medicine and Immunology
Children’’s Hospital Colorado
DR. EDWIN KIM
Associate Professor, University of North Carolina; Director UNC Food Allergy Initiative
INDRA NOOYI
Former Chairman and CEO, PepsiCo
ANN M. VENEMAN
Former US Secretary of Agriculture
PROF. KNUT LUNDIN
Professor of Medicine and Head of Clinical Education, Faculty of Medicine, University of Oslo, Norway
PROF. RAANAN SHAMIR
Chairman, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center
.jpg)
BERNHARD VAN LENGERICH
Former Chief Science Officer & VP for Technology Strategy, General Mills
